Oppenheimer & Co’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,450
Closed -$13.2K 1496
2023
Q1
$13.2K Sell
1,450
-587
-29% -$8.32K ﹤0.01% 1372
2022
Q4
$23.9K Sell
2,037
-1,173
-37% -$20.7K ﹤0.01% 1330
2022
Q3
$68K Sell
3,210
-50
-2% -$1.35K ﹤0.01% 1317
2022
Q2
$80K Sell
3,260
-87
-3% -$2.96K ﹤0.01% 1349
2022
Q1
$166K Buy
3,347
+930
+38% +$46K ﹤0.01% 1381
2021
Q4
$170K Buy
2,417
+53
+2% +$4.47K ﹤0.01% 1411
2021
Q3
$220K Sell
2,364
-134
-5% -$12.7K ﹤0.01% 1360
2021
Q2
$251K Sell
2,498
-348
-12% -$33.9K ﹤0.01% 1334
2021
Q1
$265K Buy
2,846
+212
+8% +$21.5K 0.01% 1237
2020
Q4
$217K Buy
2,634
+34
+1% +$2.9K ﹤0.01% 1216
2020
Q3
$223K Buy
2,600
+1,307
+101% +$152K 0.01% 1116
2020
Q2
$120K Buy
1,293
+420
+48% +$23.1K ﹤0.01% 1195
2020
Q1
$25K Buy
873
+343
+65% +$13.3K ﹤0.01% 1173
2019
Q4
$22K Buy
+530
New +$11.6K ﹤0.01% 1266

Other funds holding VBIV